|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Provera (Medroxyprogesterone). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (555)
Cases resulting in a serious event (554)
Cases resulting in death (24)
Cases resulting in hospitalization (91)
Cases resulting in disability (4)
Cases resulting in other serious reactions (539)
Below is a sample of reports where side effects / adverse reactions may be related to Provera (Medroxyprogesterone). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in female receiving Provera (Medroxyprogesterone)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female, weighing 57.7 kg (126.9 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Premarin
Prempro
Dosage: not specified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 2001-01-01
Prempro
Indication: Menopausal Symptoms
Provera
Adverse event in female receiving Provera (Medroxyprogesterone)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Estrace
Prempro
Provera
Adverse event in female receiving Provera (Medroxyprogesterone)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Climara
Premarin
Provera
Adverse event in female receiving Provera (Medroxyprogesterone)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Prempro / Premphase
Provera
Adverse event in female receiving Provera (Medroxyprogesterone)
Reported by a lawyer from United States on 2007-10-31
Patient: female, weighing 74.9 kg (164.8 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Prempro
Dosage: unspecified daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2002-03-01
Provera
Adverse event in female receiving Provera (Medroxyprogesterone)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer, Lung Neoplasm Malignant, Myocardial Infarction, Cerebrovascular Accident
Suspect drug(s):
Estrogen NOS
Medroxyprogesterone Acetate
Premarin
Prempro
Provera
Adverse event in female receiving Provera (Medroxyprogesterone)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1982-01-01
End date: 2001-01-01
Prempro
Indication: Menopausal Symptoms
Provera
Adverse event in female receiving Provera (Medroxyprogesterone)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Estrogen NOS
Premarin
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 1997-04-01
Provera
Adverse event in female receiving Provera (Medroxyprogesterone)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Dosage: unknown
Indication: Hormone Replacement Therapy
Medroxyprogesterone Acetate
Dosage: unknown
Indication: Hormone Replacement Therapy
Premarin
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Prempro
Dosage: unknown
Indication: Hormone Replacement Therapy
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Unspecified Estrogen Replacement Therapy
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Adverse event in female receiving Provera (Medroxyprogesterone)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in 60 year old female receiving Provera (Medroxyprogesterone)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 60 year old female, weighing 70.4 kg (154.8 pounds)
Adverse reactions / side effects: Pulmonary Embolism, Cerebrovascular Accident
Adverse event resulted in: hospitalization
Suspect drug(s):
Cycrin
Dosage: unspecified, oral
Administration route: Oral
Start date: 1989-07-01
End date: 1999-07-01
Premarin
Dosage: unspecified, oral
Administration route: Oral
Start date: 1999-07-01
End date: 1999-07-01
Provera
Adverse event in 60 year old female receiving Provera (Medroxyprogesterone)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 60 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Start date: 1986-01-01
End date: 2001-01-01
Provera
Start date: 1986-01-01
End date: 2001-01-01
Adverse event in 75 year old female receiving Provera (Medroxyprogesterone)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 75 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in 58 year old female receiving Provera (Medroxyprogesterone)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 58 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Indication: Oestrogen Replacement Therapy
Start date: 1985-01-01
End date: 1993-01-01
Provera
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1993-01-01
Adverse event in 63 year old female receiving Provera (Medroxyprogesterone)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 63 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in 61 year old female receiving Provera (Medroxyprogesterone)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 61 year old female
Adverse reactions / side effects: Breast Cancer in Situ
Suspect drug(s):
Premarin
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1993-01-01
End date: 2003-01-01
Provera
Adverse event in female receiving Provera (Medroxyprogesterone)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Cycrin
Indication: Hormone Replacement Therapy
Medroxyprogesterone
Indication: Hormone Replacement Therapy
Premarin
Indication: Oestrogen Replacement Therapy
Provera
Indication: Hormone Replacement Therapy
Adverse event in 54 year old female receiving Provera (Medroxyprogesterone)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 54 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in 50 year old female receiving Provera (Medroxyprogesterone)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 50 year old female, weighing 93.5 kg (205.7 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Provera (Medroxyprogesterone)
Reported by a lawyer from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Indication: Hormone Replacement Therapy
Premarin
Indication: Hormone Replacement Therapy
Prempro
Indication: Hormone Replacement Therapy
Provera
Indication: Hormone Replacement Therapy
Adverse event in female receiving Provera (Medroxyprogesterone)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Ovarian Cancer
Suspect drug(s):
Cycrin
Indication: Hormone Replacement Therapy
Premarin
Provera
Adverse event in 59 year old female receiving Provera (Medroxyprogesterone)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 59 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Indication: Hormone Replacement Therapy
Provera
Adverse event in 67 year old female receiving Provera (Medroxyprogesterone)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 67 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in 56 year old female receiving Provera (Medroxyprogesterone)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 56 year old female, weighing 86.2 kg (189.6 pounds)
Adverse reactions / side effects: Breast Reconstruction, Diabetes Mellitus, Goitre, Blood Triglycerides Increased, Liver Disorder, Cardiomegaly, Obesity, Induration, Breast Cosmetic Surgery, Blood Cholesterol Increased, Hypertonic Bladder, Oestrogen Receptor Assay Positive, Stress Urinary Incontinence, Cardiac Failure Congestive, Breast Cancer, Back Pain, Dyspnoea, Haematuria, Breast Mass, Atrial Fibrillation, Progesterone Receptor Assay Positive, Hepatic Steatosis, Sick Sinus Syndrome, Cardiac Pacemaker Insertion, Uterine Disorder, Pollakiuria, Mastectomy, Arthritis, Hypertension, Hyperthyroidism
Adverse event resulted in: hospitalization
Suspect drug(s):
Estraderm
Dosage: 0.1 mg, unk
Indication: Menopause
Start date: 1994-01-01
End date: 2000-01-01
Provera
Dosage: 5 mg, unk
Indication: Menopause
Start date: 1988-01-01
End date: 1989-01-01
Provera
Dosage: 5 mg, unk
Start date: 1994-01-01
End date: 2000-01-01
Vivelle
Dosage: 0.1 mg, unk
Indication: Menopause
Start date: 1997-04-01
Vivelle-DOT
Dosage: 0.1 mg, unk
Indication: Menopause
Adverse event in 50 year old female receiving Provera (Medroxyprogesterone)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 50 year old female, weighing 57.7 kg (126.9 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
|
